Japan
Tokyo and Other Japanese City, Japan
NCT Number: NCT01600001
The purpose of this study is to evaluate the efficacy and safety of KWA-0711 in Chronic Idiopathic Constipation (CIC) patients.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Phase 2
Tokyo and Other Japanese City, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 weeks
Kissei Pharmaceutical Co., Ltd.
Industry
A Randomized, Double-blind, Placebo-controlled, Phase II Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02819297
CIC, Chronic Idiopathic Constipation
Birmingham, Alabama, United States
View Trial DetailsNCT02819310
CIC, Chronic Idiopathic Constipation
Corona, California, United States
View Trial DetailsNCT01053962
Chronic Idiopathic Constipation, Colonic Diseases
Mesa, Arizona, United States
View Trial DetailsNCT01982240
Chronic Idiopathic Constipation, Constipation
Birmingham, Alabama, United States
View Trial Details